Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

NCT01016990 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: valproic acid
GENETIC: western blotting
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Auxilio Mutuo Cancer Center